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Abstract
Background: Does diet-induced obesity persist after an obesigenic diet is removed? We investigated this question by
providing male C57BL/6 mice with free access to two different obesigenic diets followed by a switch to chow to determine
if obesity was reversible.
Methodology/Principal Findings: Male C57BL/6 mice were randomly assigned to five weight-matched groups: 1) C group
that continuously received a chow diet; 2) HF group on a 60% high fat diet; 3) EN group on the high fat diet plus liquid
EnsureH; 4) HF-C group switched from high fat to chow after 7 weeks; 5) EN-C group switched from high fat plus EnsureH to
chow after 7 weeks. All food intake was ad libitum. Body weight was increased after 7 weeks on both obesigenic diets
(44.660.65, 39.860.63, and 28.660.63 g for EN, HF, and C groups, respectively) and resulted in elevated concentrations of
serum insulin, glucose, and leptin and lower serum triglycerides. Development of obesity in HF and EN mice was caused by
increased energy intake and a relative decrease of average energy output along with decreased ambulatory activity. After
the switch to chow, the HF-C and EN-C groups lost weight but subsequently maintained a state of persistent obesity in
comparison to the C group (34.861.2, 34.161.2 vs. 30.860.8 g respectively; P,0.05) with a 40–50% increase of body fat. All
serum hormones and metabolites returned to control levels with the exception of a trend for increased leptin. The HF-C and
EN-C groups had an average energy output in line with the C group and the persistent obesity was maintained despite a
non-significant increase of energy intake of less than 1 kcal/d at the end of the study.
Conclusion: Our results illustrate the importance of considering the history of energy imbalance in determining body
weight and that a persistent elevation of body weight after removal of obesigenic diets can result from very small increases
of energy intake.
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Introduction
The epidemic of obesity has profound public health implica-
tions [1]. While some individuals are genetically more suscep-
tible to develop obesity [2,3], environmental influences have
likely played a predominant role in generating the present
obesity epidemic [4,5]. Particularly important are dietary
changes resulting from increased availability of palatable, high-
energy foods [4]. To combat the problem of obesity, several
researchers have suggested substantial re-engineering of the
obesigenic environment [1,5]. But would obesity completely
reverse if the obesigenic diet was removed and replaced by a diet
that would not have produced obesity in the first place? Or does
the development of obesity result in a state that limits subsequent
weight loss even if the environment that generated obesity has
been removed?
In rodents, there are conflicting reports about the reversibility of
diet-induced obesity. While some investigators have observed
persistent obesity in rats [6–13], others have found more or less
complete obesity reversal [7,11,14–18]. The results seem to
depend on the duration and magnitude of weight gain – factors
that were often confounded because different degrees of obesity
were created by varying the length of exposure to the high energy
diet [11]. In an attempt to avoid this difficulty, we investigated the
persistence of diet-induced obesity in male C57BL/6 mice using
two different high energy diets to generate varying degrees of
weight gain before simultaneously switching to ad libitum chow to
determine whether diet-induced obesity would be reversed. For
the first time in mice, we found that temporary feeding of the
obesigenic diets resulted in a persistent elevation of body weight
and fat when compared to mice that never received the obesigenic
diets. However, most of the metabolic abnormalities that were
induced by the obesigenic diets were normalized. We also
investigated energy balance relationships, serum metabolite and
hormone concentrations, glucose and glycerol turnover rates, as
well as changes of various organ and fat pad masses.
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Animals and diets
Seventy one 3 month old male C57BL/6 mice weighing
25.961.24 g (The Jackson Laboratory, Maine) were housed
individually in conditions of controlled lighting (12 hr light,
12 hr dark) and temperature (21–22uC). All mice were fed an ad
libitum standard chow diet (Rodent NIH-07; Zeigler Bros., Inc.
PA; 3.79 kcal/g, with 24% energy derived from protein, 12%
from fat, and 64% from carbohydrate) for 14 days as an
adaptation period. Six mice were euthanized for baseline
measurements of organ and fat pad masses. The remaining mice
were then randomly assigned to five weight-matched groups as
depicted in Figure 1: 1) C group (N=18) continued on the chow
diet; 2) HF group (N=18) on a high fat diet (F3282; Bio-Serv Inc.,
NJ; 5.45 kcal/g with 14% energy derived from protein, 59% from
fat, and 27% from carbohydrate); 3) EN group (N=17) on the
high fat diet plus liquid EnsureH (Abbott Laboratories, Kent, UK),
which had an energy density of 1.06 kcal/ml with 14% of energy
derived from protein, 22% from fat, and 64% from carbohydrate;
4) HF-C group (N=6) switched from high fat to chow after 7
weeks; 5) EN-C group (N=6) switched from high fat plus EnsureH
to chow after 7 weeks. At 7 weeks, 6 mice from the C, HF, and EN
groups were euthanized to determine organ and fat pad masses
and the remaining animals progressed through week 19 when all
animals were euthanized. All animals received free access to water
and food throughout the study. The high fat diet was provided
using Rodent CAFE ´TM feeders (OYC International, Inc., MA),
and liquid Ensure was provided in a 30-ml bottle with a rodent sip
tube (Unifab Co., MI) and liquid intake was measured every day.
Solid food intake was corrected for any visible spillage and was
measured every day for the high fat diet and every other day for
the chow diet using a balance with a precision of 0.01 g (Ohaus
model SP402).
We certify that all applicable institutional and governmental
regulations concerning the ethical use of animals were followed
during this research. All procedures were approved by the
National Institute of Diabetes and Digestive and Kidney Diseases
Animal Care and Use Committee.
Measurement of body composition and organ masses
Body composition was measured once per week using 1H NMR
spectroscopy (EchoMRI 3-in-1, Echo Medical Systems LTD,
Houston, TX) after body weight was determined. At 0, 7, and 19
weeks, 6 mice from each group were randomly selected and
euthanized by cervical dislocation following i.p. administration of
Ketamine/xylazine (0.1 mg/g BW of Ketamine mixed with
0.01 mg/g BW of xylazine) between 9am and 11am. Trunk blood
was collected before naso-anal lengths were measured to the
nearest 1 mm. Heart, kidney, spleen, liver and brown adipose
tissue were harvested along with inguinal, epididymal, mesenteric,
and retroperitoneal fat pads. All organs and fat pad masses were
determined to within 0.1 mg precision.
Serum metabolites and hormones
At weeks 0, 7, and 19, trunk blood from the sacrificed animals
was used for the analysis of serum metabolites and hormones in
the fed state. Serum insulin and leptin were measured using
radioimmunoassay kits (SRI-13K and ML-82K respectively; Linco
Research, St. Charles, MO). Serum glucose was measured using a
Glucometer Elite (Bayer, Elkhart, IN). Serum free fatty acids, total
triglycerides, and free glycerol were measured using commercially
available kits from Roche Diagnostics Corp., Thermo Electro Inc.,
and Randox Lab Ltd., respectively.
Ambulatory activity
Ambulatory activity was measured using the Oxymax system
(Columbus Instruments, Columbus, Ohio, USA; 2.5 L chambers
with wire mesh floors) with 1 mouse per chamber. The chamber
sides were equipped with a mouse sensor (Opto-Varimex mini,
Columbus Instruments; 16 beams of infrared at 0.5 inches apart).
Ambulatory activity was recorded by counting the first beam
interruption, but ignoring further interruptions unless other beams
were restored or interrupted in the same time period. At the end of
weeks 7 and 19, six mice from each C, HF, and EN group were
housed in the chambers with free access to food and water for two
days. We report the average of the measurements over the two
days for each group.
Glucose and glycerol turnover rates
Glucose and glycerol turnover were measured in restrained,
conscious mice in the non-fasted state. At the beginning of the
study, 6 mice were used for baseline measurements. Another 18
mice were randomly assigned to three groups on the chow, high
fat diet, and high fat diet plus Ensure, respectively. At the end of
study (week 19), 6 mice from each of the C, HF, and EN groups
had catheters surgically inserted into their jugular veins. The
procedures for catheter insertion and turnover measurements were
adapted from Chen et al [19]. Two HF mice and one EN mouse
did not survive the surgery. After 4–5 days of recuperation from
the surgery, glucose and glycerol turnover rates were determined
by continuously infusing [1–14C] glucose (3 mCi bolus, then
0.02 mCi/min) and [2–3H] glycerol (10 mCi bolus, then 0.1 mCi/
min). Blood samples (30 ml) were taken from the tail vein at 0, 75,
90, 105 and 120 min. The concentrations of glucose in plasma
were analyzed with a glucose oxidase method (YSI 2700 Select;
Yellow Springs Instruments, Yellow Springs, OH); free glycerol
was measured calorimetrically (Randox Lab Ltd, Oceanside, CA ).
Glucose and glycerol concentrations in the samples between 75
and 120 min of tracer infusion were stable suggesting that a steady
state was achieved. The blood samples were deproteinized with
ZnSO4 and Ba(OH)2, dried to remove 3H2O, re-suspended in
water, and counted in scintillation fluid (BioSafe II, Research
Product International Corp., Mount Prospect, IL) on dual
channels to provide separation of 3H and 14C counts for the
determination of plasma [2–3H]glycerol and [1–14C]glucose,
respectively. The appearance rates for glucose and glycerol were
calculated using the following equation:
Figure 1. Experiment design. For the first 7 weeks two groups of
weight-matched mice were fed different obesigenic diets, either a high
fat solid diet or a high fat solid diet plus liquid Ensure. Subsequently, 6
mice from each group that were fed the obesigenic diets were switched
to the standard chow diet for the remaining 12 weeks. All food and
liquid intake was ad libitum.
doi:10.1371/journal.pone.0005370.g001
Persistent Obesity
PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5370Ra~I|Cplasma|Scpm

Pcpm
where Ra=appearance rate in mmol/min, I=infusion rate in ml/
min, Scpm=scintillation counts in stock solution, Pcpm=scintillation
counts in plasma, and Cplasma=plasma glucose or glycerol
concentration in mmol/ml.
Calculations and statistical analysis
To calculate body energy changes, DBE, we assumed that
changes of body fat had an energy density of 9.4 kcal/g whereas
fat-free mass changes had an energy density of 1.8 kcal/g [20].
Since energy is conserved, the average total energy output rate
over a given time period, T, was calculated as:
SEOTT~SEITT{DBE=T
where ,EI.T was the average energy intake over the time period,
T. This equation is simply the energy balance equation averaged
over the time interval T. We distinguish energy output from
energy expenditure since we did not measure the energy content of
feces and urine which contribute a small amount to the energy
output [21]. In other words, energy output is defined as the sum of
energy expenditure plus energy excreted.
Data were analyzed by analysis of variance using PROC
MIXED (SAS, 1999). Tukey’s method was used to adjust pairwise
differences for multiple comparisons. Regression analysis was
performed using the least square method. Significance was
declared at P,0.05, unless otherwise noted. Means6SEM are
reported and significant differences were indicated in the figures
using different superscripts. The letter superscripts, a, b, c, indicate
differences across the groups within each time period. The
numbered superscripts, 1, 2, 3 indicate within group differences
across the time periods.
Results
Food intake
During the first 7 weeks, the animals that were simultaneously
provided with the high fat diet and liquid Ensure (the EN and EN-
C groups) consumed significantly more energy than the mice given
the high fat diet alone (the HF and HF-C groups; P,0.01), and all
of these groups consumed more than the mice provided with the
standard chow diet (the C group) (Figure 2A; P,0.01). The EN
and EN-C groups had reduced solid food intake versus the HF and
HF-C groups and the liquid Ensure provided about half of their
energy intake. Figure 2B shows that the EN and EN-C groups
consumed a similar amount of carbohydrate as the animals on the
chow diet (7.4660.13 and 7.5960.17 vs. 7.6860.17 kcal/day,
respectively; P.0.499) and slightly less fat than the animals on the
high fat diet alone (6.8960.12 and 7.2860.16 vs. 7.9160.16 and
8.3260.22 kcal/day, respectively; P,0.05).
After the switch to standard chow diet at 7 weeks, the energy
intakes of the HF-C and EN-C groups fell immediately to a level
significantly lower than the C group and the mice ate less than the
C group over the next 2 weeks (P,0.01). During the final 10 weeks
of the study, the energy intakes of the HF-C and EN-C groups
were within 1 kcal/d of the C group (12.960.5, 12.860.5, and
12.160.3 kcal/d, respectively; P.0.15). The HF group consumed
13.360.3 kcal/d which was significantly higher than the C group
(P=0.01). Finally, the EN group consumed 17.260.4 kcal/d
which was significantly greater than all other groups (P,0.01).
Body weight
The mean body weight for each group is shown in Figure 3A.
Body weight was significantly higher after 1 week of the HF and EN
diets when compared with the C group (30.460.40, 30.960.41 vs.
26.560.40 g respectively; P,0.01). After receiving the high fat diet
plus liquid EnsureH for 4 weeks, the EN group became significantly
heavier than the HF group (39.560.58 vs. 36.260.58 g; P,0.01).
Because the same diet was given to the HF-C and HF groups in the
first 7 weeks of the experiment, these two groups had similar body
weights (P.0.20). Similarly, the EN-C and EN groups had similar
body weights after 7 weeks (P.0.36) which were significantly higher
than the HF and HF-C groups (P,0.01).
After the switch to chow at 7 weeks, both the HF-C and EN-C
groupsrapidlylostweight.However,theirbodyweightstabilizedata
level significantly higher than the C group (P,0.05). Interestingly,
although the HF-C and EN-C groups had different body weights at
the time of diet switch, they maintained the same level of persistent
obesity for the remainder of the study (34.861.21, 34.161.21 vs.
30.860.85 g respectively; P,0.05). At week 19, the EN group was
significantly heavierthan the HFgroup (53.860.89 vs. 47.560.85 g;
P,0.01), and both the EN and HF groups had greater body weights
compared with their corresponding diet-switch groups, the EN-C
and HF-C groups respectively (P,0.05).
Body fat
Figure 3B shows the mean body fat mass for each group which
followed a similar pattern to the body weight curves. The EN
group gained more fat mass than the HF group at week 7
(17.260.47 vs. 14.760.45 g respectively; P,0.01) as well as at
week 19 (21.360.62 vs. 19.460.60 g respectively; P,0.05). The
fat masses of the HF-C and EN-C groups decreased after the
switch to chow, but stabilized at the same level that was
significantly higher than that in the C group and remained at
that level throughout the remainder of the study (7.960.85 and
7.360.85 vs. 5.260.60 g at week 19, respectively; P,0.05).
The percent body fat in the HF and EN groups followed a
similar pattern throughout the experiment, as did the HF-C and
EN-C groups (Figure 3D). The HF and EN groups had greater
percent body fat than the control group at week 7 (36.860.76%
and 38.660.62% vs. 12.560.94%, respectively; P,0.01), and
both the HF and EN groups stayed at a similar body fat
percentage throughout the remainder of the study (40.960.67%
vs. 39.560.62% at week 19, respectively; P=0.34). The percent
body fat of the HF-C and EN-C decreased after the switch to chow
diet, but remained significantly higher than that of the control
group (22.062.70% and 21.361.16% vs. 16.761.14% at week
19, respectively; P,0.01).
Fat-free mass and body length
Figure 3C shows that the mice receiving high fat diet plus liquid
EnsureH (EN and EN-C groups) had greater fat-free mass than
those on the high fat diet alone (HF and HF-C groups) or on the
chow diet at week 7 (26.460.38 vs. 24.160.37 and 23.860.37 g
respectively; P,0.01). Although the difference between the HF
and C groups was not significant at week 7 (P.0.47), at week 19
the HF group gained more fat-free mass than the control group
(26.660.37 vs. 24.060.37 g respectively; P,0.01) but had a lower
fat-free mass than the EN group (30.760.39 vs. 26.660.37 g
respectively; P,0.01). The EN-C group had a significant drop in
fat-free mass (P,0.05) 1 week after the switch to the chow diet
whereas the HF-C group maintained their fat-free mass.
Consequently the HF-C and EN-C groups maintained almost
identical fat-free masses (25.260.53 g for both the groups at week
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only tended to be greater than the control group (P=0.086).
Importantly, the fat-free mass results were consistent with body
lengthmeasurements.Attheendoftheexperimentthebody lengthin
the EN group was the longest among the five groups (10.360.14 cm;
P,0.05). The HF, HF-C and EN-C groups also tended to have
increased body length compared to the control group (9.860.12,
9.860.17, 9.960.13 vs. 9.560.10 cm respectively, P,0.10).
Energy deposition, output and ambulatory activity
Figure 4A plots the gain of body energy as a function of the
cumulative energy intake for the individual animals in each diet
group after 19 weeks. There was clearly a positive correlation
between energy intake and body energy gain (r=0.74, P,0.01),
but the body energy gain in the HF and EN groups was
disproportionately higher than the other groups indicating
increased energy deposition efficiency in these mice (P,0.01).
To further explore this observation, we calculated the average
energy output as a function of the average energy intake as
depicted in Figure 4B. The dashed line is the line of identity
indicating a state of average energy balance. The data clearly
separated into two lines relating average energy output and
energy intake rates, with the HF and EN animals falling on a line
below that of the other groups. Regression analysis revealed
Figure 2. Ad libitum energy intake of male C57BL/6 mice from each diet group. The 5 diet groups: chow diet (C), high fat diet (HF), high fat
diet plus EnsureH (EN), high fat diet for 7 wk followed by a switch to chow (HF-C), and high fat diet plus EnsureH for 7 wk followed by a switch to
chow (EN-C). Panel A shows the energy intake derived from solid food (open bars) versus liquid Ensure (filled bars). Panel B shows the macronutrient
content of the diets indicating the protein intake as open bars, carbohydrate intake as striped bars and fat intake as solid bars. Values are mean6SEM.
Statistical differences among the means were determined by performing an analysis of variance. Pairwise differences were adjusted for multiple
comparisons by Tukey’s method. Different letters indicate significant differences of total energy intake rate across groups within each time period
(P,0.05). Different numbers indicate significant within-group differences of total energy intake rate across the time periods (P,0.05).
doi:10.1371/journal.pone.0005370.g002
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P=0.45), but the y-intercept was significantly decreased for the
HF and EN animals (20.2160.28 vs. 0.9760.44 kcal/d;
P,0.01). Therefore, feeding the obesigenic diets decreased the
average energy output rate by 1.260.5 kcal/d after adjusting for
energy intake (P,0.05). The relative decrease of the average
energy output rate of the HF and EN groups corresponded to
significantly lower average ambulatory activity versus the C
group (Figure 4C) implying that at least part of the effect of the
obesigenic diets on average energy output was due to decreased
ambulatory activity.
Figure 4D shows that the average energy intake rate of the mice
over the last two weeks of the study was positively correlated with
body weight (r=0.82, P,0.01) and the slope of the regression line
was 0.2160.02 kcal/g/d. Since the body weight was relatively
steady at the end of the study, the energy output rate was
approximately equal to the energy intake rate and therefore
energy output was also positively correlated to body weight
according to the same relationship.
Organ and fat pad masses
Table 1 reports the liver, spleen, kidney, and heart masses for
each diet group at weeks 0, 7, and 19. After 7 weeks, the high fat
plus liquid Ensure diet resulted in increased liver, spleen, and heart
masses versus chow or high fat diet alone (P,0.05). The kidney
mass also tended to be higher in the EN group versus the C group
(P=0.065). These organ mass differences were more pronounced
by week 19 (P,0.05). High-fat feeding alone had a significant
effect on the heart mass, which was 28% higher in the HF group
compared to the C group at week 19 (P,0.05). In the HF-C and
EN-C groups, liver, spleen, kidney, and heart masses were all
normalized at week 19.
Table 2 shows how body fat was distributed across the major fat
pads: mesenteric, retroperitoneal, epididymal, inguinal, and brown
adipose tissue. As expected, all fat pads were enlarged in the HF
and EN groups at weeks 7 and 19 compared with the C group. At
week 7, the EN group had increased brown and mesenteric
adipose tissue versus the HF group, but the mass of epididymal fat
tended to be greater in the HF group versus the EN group at week
7( P ,0.10), and this difference became more pronounced by the
end of the study (P,0.05). Interestingly, the epididymal fat pad
mass decreased by more than 25% in both the HF and EN groups
from weeks 7 to 19 (P,0.05) despite the overall increase of body
fat mass.
After switching to the chow diet, the HF-C and EN-C groups
had decreased fat pad masses versus the HF and EN groups at
week 19 (P,0.05). However, the HF-C group retained higher
mesenteric, epididymal, and inguinal fat pad masses versus the C
group at week 19 (P,0.05). Although not statistically significant,
the EN-C group had a trend for higher inguinal fat pad mass
compared with the control group (P=0.12).
Blood parameters
After 7 weeks, the high fat plus EnsureH diet significantly
increased serum glucose, insulin, and leptin concentrations and
decreased total triglyceride concentrations in the EN group
versus the C group (P,0.05; Table 3). Feeding the high fat diet
alone significantly increased the serum glucose and leptin levels
Figure 3. Body weight and body composition in male C57BL/6 mice from each group. Body weight (Panel A), fat mass (Panel B), fat free
mass (Panel C), and percent body fat (Panel D) in male C57BL/6 mice from 5 diet groups: chow diet (C), high fat diet (HF), high fat diet plus EnsureH
(EN), high fat diet for 7 wk followed by a switch to chow (HF-C), and high fat diet plus EnsureH for 7 wk followed by a switch to chow (EN-C). Values
are mean6SEM and the error bars were often smaller than the size of the data point marker.
doi:10.1371/journal.pone.0005370.g003
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versus C groups (P,0.05). These changes were further
exacerbated after 19 weeks (P,0.05). Twelve weeks after the
diet switch, the HF-C and EN-C groups normalized all blood
parameters with the exception of a trend for higher circulating
leptin concentrations (P=0.13 and 0.28 for HF-C and EN-C vs.
C, respectively).
Glycerol and glucose turnover rates
Table 4 shows that the rates of glucose and glycerol turnover in
the C group did not change from week 7 to week 19 (P.0.3).
However, after 19 weeks the mice in the HF and EN groups had
greater glycerol and glucose appearance rates compared to the
control animals (P,0.05). No significant difference was observed
between the HF and EN groups. However, there was a marginal
Figure 4. Energy intake, energy output, change of body energy, and ambulatory activity. Body energy changes versus cumulative energy
intake over the 19 week experiment (Panel A) and the calculated 19 week average energy output rate versus average energy intake rate (Panel B). The
data points indicate individual mice from the 5 diet groups: chow diet (C), high fat diet (HF), high fat diet plus EnsureH (EN), high fat diet for 7 wk
followed by a switch to chow (HF-C), and high fat diet plus EnsureH for 7 wk followed by a switch to chow (EN-C). In panel B, the dotted line is the line
of identity indicating average energy balance. The solid line is the best-fit regression line for the C, HF-C, and EN-C groups (slope=0.9060.03,
intercept=0.9760.44 kcal/d, R2=0.98) and the dashed line is the best-fit regression line for the HF and EN groups (slope=0.9260.02,
intercept=20.2160.28 kcal/d, R2=0.99). C) The average ambulatory activity of the mice measured at weeks 7 and 19. The bars with different letters
indicate significant differences of ambulatory activity within each time period (P,0.05). Panel D plots the energy intake rate over the last two weeks
of the study as a function of the final body weight (slope=0.2160.02 kcal/g/d, intercept=4.9960.93 kcal/d, R2=0.67). The regression analysis was
performed using the least square method and other statistical analyses were performed as in Figure 2.
doi:10.1371/journal.pone.0005370.g004
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compared with the HF group (P=0.127). Regression analysis
revealed that the glucose turnover rates were correlated with fat-
free mass across all the groups (r=0.85, P,0.01) and glycerol
appearance rates were correlated with body fat mass (r=0.62,
P,0.01).
Discussion
This is the first report of persistent diet-induced obesity in mice.
Two previous studies also using C57BL/6 mice did not observe
persistent obesity following removal of high fat diets [17,18]. But
these previous studies used younger mice (4–6 weeks of age vs. 3
months old in the present study) that were housed in groups of 5
animals per cage as opposed to individual housing. These factors,
along with differences in the composition of the diets, likely
contributed to our unique observation that returning mice to a
non-obesigenic diet after 7 weeks of exposure to two different
obesigenic diets resulted in sustained elevations of body fat by 40–
50% when compared with mice that were never exposed to the
obesigenic diets.
Of course, the persistence of obesity for 12 weeks following the
return to a non-obesigenic diet does not prove that these mice
would have permanent alterations of body weight and composi-
tion. Nevertheless, this period of time represents a significant
fraction of the average lifespan of these mice (about 10 percent)
and was more than 70% longer than the period of obesity
induction. Furthermore, unlike the previous observations of
persistent diet-induced obesity in rats that occurred on a
background of significant growth [6–13], our chow fed mice
increased their fat-free mass by less than 5% over the 19 week
study. Thus, beginning the study with 3 month old mice achieved
relative stability of lean tissue mass in the control group and
allowed diet interventions of sufficient duration while avoiding
confounding factors of advanced age.
Interestingly, the different average body weights and fat masses
attained after 7 weeks of HF versus EN diets did not impact the
final level of persistent obesity (Figure 3). This suggests that both
diets resulted in sufficient weight gain to cross a threshold for
inducing a fixed increment of persistent body weight gain. In
contrast, a graded effect would be expected to result in different
levels of persistent obesity for varying degrees of diet-induced
weight gain. This did not happen. Rather, our observations are
consistent with a previously suggested mechanism of inducing
multiple body weight set points generated by acquired leptin
resistance during the high energy diets [22,23]. Future studies
could potentially locate the threshold weight gain required to
achieve persistent obesity by varying the dietary fat percentage to
scan a range of body weight gains over the 7 week obesigenic
period.
To help understand the energy imbalances underlying our
results, we used the principle of energy conservation to calculate
the average energy output rate as a function of the average energy
intake rate (Figure 4B). This analysis revealed that HF and EN
mice had decreased average energy output relative to their average
energy intake. Decreased average ambulatory activity in the HF
and EN mice (Figure 4C) likely contributed to this relative
reduction of energy output and similar behavior was recently
observed in C57BL/6 mice fed with a high fat diet [21]. The mice
in the diet switched groups, HF-C and EN-C, had average energy
output rates that fell on the same line as the C group implying that
their average energy output was comparable to the control group.
The HF-C and EN-C mice cumulatively consumed more
energy than the control mice, but there were no statistically
significant differences between the energy intake rates of the HF-
C, EN-C, and C groups over the last several weeks of the study
(Figure 2A) despite the steady elevation of body weight. While not
Table 1. Organ masses.
Period
Diet
group Liver (g) Spleen (g) Kidney (g) Heart (g)
Week 0 C 1.3060.125 0.0860.008 0.3460.027 0.1360.007
Week 7 C 1.4760.086
b 0.0860.005
b 0.3660.038 0.1360.015
b
HF 1.5460.074
b 0.0860.008
b 0.4160.062 0.1560.008
b
EN 2.3260.350
a 0.1160.016
a 0.4260.043 0.1960.048
a
Week 19 C 1.5460.123
b 0.0960.009
b 0.4260.035
bc 0.1460.020
c
HF 2.3060.352
b 0.1060.007
b 0.4160.030
c 0.1860.019
b
HF-C 1.6760.235
b 0.0960.012
b 0.4760.021
ab 0.1560.008
bc
EN 5.2361.592
a 0.1760.020
a 0.5160.071
a 0.2060.035
a
EN-C 1.6760.196
b 0.0960.008
b 0.4560.058
bc 0.1560.012
c
Data are presented as means6SEM. N=6 for all the groups except for the EN
group at week 19 where N=5. Within each period, different letters indicate
significant differences between treatments (P,0.05).
doi:10.1371/journal.pone.0005370.t001
Table 2. Fat pad masses.
Period Diet group BAT (mg) MES (mg) RET (mg) EPI (mg) ING (mg)
Week 0 C 92618 193643 109630 404675 324662
Week 7 C 11468
c 229666
c 2656109
b 7116201
b 5386161
b
HF 265624
b 10096145
b 10916166
a 28486266
a 17606175
a
EN 462631
a 14626323
a 12826309
a 24686532
a 17596458
a
Week 19 C 163617
c 352678
d 4296164
c 10536266
d 6666145
c
HF 451620
b 16056121
a 17456239
b 20946138
a 28216144
a
HF-C 193680
c 5116197
c 6296205
c 14046334
bc 10426549
b
EN 7436128
a 1304664
b 24446548
a 16816440
b 27296185
a
EN-C 201643
c 391697
cd 428688
c 11346103
cd 9496257
bc
Abbreviation:BAT:brownadiposetissue,MES:mesentericfatpad,RET:retroperitonealfatpads,EPI:epididymal fatpads,ING:inguinalfatpads.N=6forall thegroupsexcept
for the EN group at week 19 where N=5. Values are means6SEM. Within each period, different letters indicate significant differences between diet groups (P,0.05).
doi:10.1371/journal.pone.0005370.t002
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EN-C mice at the end of the study were numerically greater than
the C group, but within 1 kcal/d. Significant differences of body
weight can be maintained by very small differences of energy
intake thereby putting severe constraints on the ability to
experimentally detect such differences. For example, the slope of
the regression line relating energy intake and body weight at the
end of our experiment (Figure 4D) was only 0.2160.02 kcal/g/d
which means that less than 1 kcal/d of additional energy intake
would be required to maintain the 4 g of additional body weight
observed in the HF-C and EN-C groups at the end of the study.
While this difference of body weight is easily measured, detecting
such a small difference of energy intake or output is technically
challenging. Similar considerations suggest the potential impor-
tance of alterations of gut absorption [24,25] resulting in changes
of energy excretion in urine and feces which were not directly
measured in the present study, but were included in our
calculations of energy output.
These observations highlight an important fact that is often
overlooked in studies of obesity: changes of body weight indicate
past cumulative energy imbalance and understanding the genesis
of body weight differences requires knowledge about this history in
addition to measurements made at isolated time points [26].
Because the relationship between steady-state energy expenditure
versus body weight has such a shallow slope, isolated measure-
ments of energy intake or output rates may be unable to detect
statistically significant differences between groups that have clearly
different body weights. This difficulty may lead to the potentially
erroneous conclusion that the lack of a statistically significant
difference implies that there is in fact no difference and therefore
altered energy efficiency must underlie the body weight differences
– often illustrated by somehow normalizing the measurements for
body weight [27]. In contrast, by taking into consideration the
history of energy imbalance, the present study suggests that very
small increases of energy intake likely explain the persistent obesity
observed in the HF-C and EN-C mice.
The pattern of body fat accumulation in obesity is believed to
play a role in disease risk [28–31] and we found interesting
dynamics of body fat accumulation in the various fad pads during
the development of obesity (Table 2). Both obesigenic diets led to
dramatic increases of all fat pads at weeks 7 and 19 versus the
modest increases observed in the chow group. However, not all fat
pads monotonically increased in size on the obesigenic diets.
Rather, the epididymal fat pads decreased by more than 25%
between weeks 7 and 19 in the HF and EN groups despite increases
of the other fat pad masses as well as overall body fat. This
observation is consistent with a recent report showing a non-
monotonic relationship between epididymal fat mass and body
weight that was associated with adipose tissue remodeling during the
development of diet-induced obesity [32]. In the mice that were
switched from the obesigenic diets back to chow, all fat pad masses
were decreased at week 19 in comparison to their corresponding
masses at week 7. However, in reflection of their persistent obesity,
the HF-C group retained significant elevations of mesenteric,
epididymal, and inguinal fat pad masses versus the C group at week
19 and a similar trend was observed in the EN-C group.
Both obesigenic diets resulted in increased serum leptin, insulin,
and glucose, but triglycerides were paradoxically lower. After the
switch to chow, all serum measurements returned to control values
at week 19, with the exception of leptin which tended to remain
increased in the persistent obese HF-C and EN-C mice versus the
control group (Table 3). The HF and EN mice that continued
their obesigenic diets for the entire 19 weeks had further
deterioration of their metabolic state with increased serum glucose,
insulin, and leptin concentrations while curiously maintaining
lower serum triglycerides (Table 3).
Paradoxically decreased circulating triglycerides (TG) have been
previously found in high fat fed C57BL/6 mice despite their
insulin resistant state [33]. While reduced dietary carbohydrate
might explain these previous observations and why we also found
lower serum TG in the HF group versus the C group, the EN
Table 3. Serum glucose, NEFA, glycerol, triglycerides, leptin, insulin concentrations.
Period Diet group Glucose (mg/dl) FFA (mM) Glycerol (mM) Triglyceride (mg/dl) Leptin (ng/ml) Insulin (ng/ml)
Week 0 C 229615 0.2860.014 197614 76.563.58 3.360.43 0.260.01
Week 7 C 22968
b 0.2760.018 233614 79.764.76
a 6.961.10
b 0.860.18
b
HF 28368
a 0.3060.085 242636 47.265.28
b 57.8613.0
a 1.360.41
b
EN 300622
a 0.3160.056 268631 53.667.29
b 70.2617.9
a 3.962.68
a
Week 19 C 279639
b 0.2660.059
b 212652
bc 84.7624.1
ab 9.863.6
b 0.760.14
b
HF 344647
a 0.3760.068
a 255625
ab 51.2616.2
c 82.6615.1
a 2.360.42
b
HF-C 278639
b 0.3260.139
ab 189650
c 90.3627.6
a 19.0611.4
b 0.960.32
b
EN 352633
a 0.3960.081
a 308639
a 65.3618.7
bc 84.5611.4
a 6.865.34
a
EN-C 268641
b 0.2660.048
b 196623
c 85.1619.9
ab 16.466.1
b 1.060.40
b
Values are means6SEM. Within each period, different letters indicate significant differences between diet groups (P,0.05). Week 19 glycerol C vs. EN, P=0.1164; week
19 leptin HF vs. EN, P=0.1245; N=6 for all the groups except for the EN group at week 19 where N=5.
doi:10.1371/journal.pone.0005370.t003
Table 4. Glycerol and glucose turnover rates.
Period Diet group
Glycerol Appearance Rate
(mmol/min per mouse)
Glucose
Appearance Rate
(mmol/min per mouse)
Week 0 C 0.21260.021 2.9760.45
Week 19 C 0.21760.025
b 3.0660.40
b
HF 0.31260.072
a 4.3660.98
a
EN 0.29860.081
a 5.0460.50
a
Glucose Appearance Rate HF vs. EN, P=0.1266. N=4, 5, 6 and 6 for the HF, EN,
and the two control groups respectively. Values are means6SEM. Within each
period, different letters indicate significant differences between diet groups
(P,0.05).
doi:10.1371/journal.pone.0005370.t004
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but also had decreased serum TG. Since both the EN and HF
groups consumed similarly high amounts of dietary fat, perhaps
the increased fat intake (rather than the reduced carbohydrate
intake) caused the observed lowering of circulating triglycerides
either by suppressing TG production and/or increasing TG
clearance. Further support for this hypothesis comes from the
study by Meugnier et al. who measured decreased circulating TG
concentrations after adding 550 kcal/d of fat to the daily diet of
lean men while keeping carbohydrate intake constant [34].
A possible alternative mechanism for the reduced serum TG
levels could have been the elevated insulin concentrations
observed in both the HF and EN groups since insulin is known
to acutely inhibit hepatic VLDL secretion [35] and stimulate
adipose TG uptake via LPL [36]. However, chronic elevations of
insulin consequent to insulin resistance typically go along with
high VLDL secretion and correspondingly high circulating TG
[37]. Furthermore, both HF and EN groups had increased rates of
whole body lipolysis as reflected by elevated glycerol appearance
rates (Table 4) and increased serum glycerol and FFA concentra-
tions (Table 3). Thus, adipose tissue was not responding to the
elevated insulin and the resulting increased FFA supply to the liver
would be expected to increase VLDL secretion and thereby
increase rather than decrease serum TG. Clearly, more work is
required to understand the mechanism for lowering serum TG
during high fat feeding.
The cause of the obesity epidemic is typically attributed to an
environment that promotes excessive food intake and limits
physical activity [1,5]. Thus, a possible solution to the obesity
problem involves re-engineering the obesigenic environment
towards one that would not have resulted in obesity. The present
study raises the possibility that even such a dramatic change of the
environment may not be sufficient to completely reverse obesity.
Nevertheless, the return to the non-obesigenic environment
allowed the persistently obese mice to normalize their previously
increased serum concentrations of glucose, insulin, leptin, free fatty
acids, and glycerol, while their paradoxically low serum triglyc-
erides increased to normal values. While the energy intake rate of
the persistently obese mice was within 1 kcal/d of the control mice
at the end of the study, we believe that such a small increase likely
explains the persistent elevation of body weight and fat mass.
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